
Zrs Pharmaceuticals India Private Limited
Founded in 2021 and headquartered in Delhi, India.
Founded in 2021 and headquartered in Delhi, India.
Zrs Pharmaceuticals India Private Limited (ZPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 2021 (Three years and eight months 3 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Rachna Bansal, Meenakshi Gupta, Harish Yadav, and One other member serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U24304DL2021PTC386179
386179
Private Limited Indian Non-Government Company
06 Sep 2021
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Zrs Pharmaceuticals India Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antiepileptic Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Cardiovascular Drugs & Medication, Kidney Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Dietary Supplements, Pain Relief Drugs & Pharmaceuticals.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Meenakshi Gupta ![]() | Director | 06-Sep-2021 | Current |
Harish Yadav ![]() | Director | 06-Sep-2021 | Current |
Rachna Bansal ![]() | Director | 06-Sep-2021 | Current |
Sohan Poonia ![]() | Director | 06-Sep-2021 | Current |
Zrs Pharmaceuticals India Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 315.37% increase. The company also saw a substantial fall in profitability, with a 12.18% decrease in profit. The company's net worth Soared by an impressive increase of 608.98%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Zrs Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Rachna Bansal is a mutual person
₹10.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
27 Jan 2025 | Others | ₹1.00 Cr | Open |
Zrs Pharmaceuticals India has a workforce of 10 employees as of Apr 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zrs Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zrs Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 10.00 M with Charge ID 101043518 was registered on 27 Jan 2025.
Zrs Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Zrs Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Rachna Bansal was appointed as a Director was appointed as a Director on 06 Sep 2021 & has been associated with this company since 3 years 8 months .
Meenakshi Gupta was appointed as a Director was appointed as a Director on 06 Sep 2021 & has been associated with this company since 3 years 8 months .
Harish Kumar Yadav was appointed as a Director was appointed as a Director on 06 Sep 2021 & has been associated with this company since 3 years 8 months .
Zrs Pharmaceuticals India Private Limited was incorporated on 06 Sep 2021.
The authorized share capital of Zrs Pharmaceuticals India Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 4 directors are associated with Zrs Pharmaceuticals India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Zrs Pharmaceuticals India Private Limited is House No.-87 Ist Floor Deepali Enclave Chowk, Pitampur India, Delhi, 110034.
The corporate identification number (CIN) of Zrs Pharmaceuticals India Private Limited is U24304DL2021PTC386179 and the company number is 386179 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2024, the revenue trend for Zrs Pharmaceuticals India Private Limited has risen by 315.37%.
As Per 2024 financial reports, 10 employees are currently employed by Zrs Pharmaceuticals India Private Limited.
The financial reports for the fiscal year 2024 indicates that The net worth of Zrs Pharmaceuticals India Private Limited has experienced an upsurge of 608.98%.
As per the financial statements for fiscal Year 2024, The total open charges for Zrs Pharmaceuticals India Private Limited amount to ₹ 1.00 Cr.
The most recent Balance Sheet for Zrs Pharmaceuticals India Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.